Actively Recruiting
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
Led by Seoul National University Bundang Hospital · Updated on 2023-04-13
2000
Participants Needed
1
Research Sites
1278 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To assess antimicrobial resistance rates and minimal inhibitory concentrations in H. pylori isolated from patients with upper gastrointestinal disease with long-term period.
CONDITIONS
Official Title
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects who had a H. pylori infection and consented to undergo culture analysis via endoscopic resection to determine minimal inhibitory concentration (MIC) of antibiotics.
You will not qualify if you...
- Patients with a concurrent critical illness.
- Patients who abuse drugs or alcohol.
- Patients who are pregnant or nursing.
- Patients who received antibiotics, proton pump inhibitors, or bismuth salts within 4 weeks prior to the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620
Actively Recruiting
Research Team
J
Jung Won Lee, M.D.
CONTACT
N
Nayoung Kim, M.D., Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here